The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice
The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
The mechanisms responsible for the evolution of steatosis towards NASH (non-alcoholic steatohepatitis) and fibrosis are not completely defined. In the present study we evaluated the role of CD4+ T-helper (Th) cells in this process. We analysed the infiltration of different subsets of CD4+ Th cells in C57BL/6 mice fed on a MCD (methionine choline-deficient) diet, which is a model reproducing all phases of human NASH progression. There was an increase in Th17 cells at the beginning of NASH development and at the NASH–fibrosis transition, whereas levels of Th22 cells peaked between the first and the second expansion of Th17 cells. An increase in the production of IL (interleukin)-6, TNFα (tumour necrosis factor α), TGFβ (transforming growth factor β) and CCL20 (CC chemokine ligand 20) accompanied the changes in Th17/Th22 cells. Livers of IL-17−/− mice were protected from NASH development and characterized by an extensive infiltration of Th22 cells. In vitro, IL-17 exacerbated the JNK (c-Jun N-terminal kinase)-dependent mouse hepatocyte lipotoxicity induced by palmitate. IL-22 prevented lipotoxicity through PI3K (phosphoinositide 3-kinase)-mediated inhibition of JNK, but did not play a protective role in the presence of IL-17, which up-regulated the PI3K/Akt inhibitor PTEN (phosphatase and tensin homologue deleted on chromosome 10). Consistently, livers of IL-17−/− mice fed on the MCD diet displayed decreased activation of JNK, reduced expression of PTEN and increased phosphorylation of Akt compared with livers of wild-type mice. Hepatic infiltration of Th17 cells is critical for NASH initiation and development of fibrosis in mice, and reflects an infiltration of Th22 cells. Th22 cells are protective in NASH, but only in the absence of IL-17. These data strongly support the potentiality of clinical applications of IL-17 inhibitors that can prevent NASH by both abolishing the lipotoxic action of IL-17 and allowing IL-22-mediated protection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CD4 + T H 17 cells and CD8 + T cells have been shown to mediate NASH-associated liver fibrosis in both mice and humans (5-9).”
From NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis (2023) · cites this paper as [7]
In the citing paper
“Deficiency of this cytokine or its signalling components results in decreased hepatic accumulation of myeloid cells in models of NASH (7,52).”
From NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis (2023) · cites this paper as [7]
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
The lineage decisions of helper T cells
Murphy, K. M., & Reiner, S. L. (2002) · Nature Reviews Immunology · doi:10.1038/nri954 · Cited by 1,674
Liver fibrosis and repair: Immune regulation of wound healing in a solid organ
Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3623 · Cited by 1,310
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,143
Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A., & Sallusto, F. (2009) · Nature Immunology · doi:10.1038/ni.1767 · Cited by 1,079
Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K., Asano, M., & Iwakura, Y. (2002) · Immunity · doi:10.1016/s1074-7613(02)00391-6 · Cited by 1,052
Cited by
Items 101–161 of 161
Pan, Y., Ren, X., Zhang, Y., Lv, J., Zeng, Q., Zhang, H., & Yu, Z. (2018) · IUBMB Life · doi:10.1002/iub.1960 · Cited by 14
The Development of Systemic Inflammatory Diseases in Hidradenitis Suppurativa
Saito‐Sasaki, N., & Sawada, Y. (2023) · Diagnostics · doi:10.3390/diagnostics13030502 · Cited by 14
Hu, J., Shao, Y., Gui, C., Xiao, Y., Li, L., & Li, Z. (2024) · Medicine · doi:10.1097/md.0000000000038007 · Cited by 16
Su, S.-B., Zhang, J., Huang, F., Cen, Y., & Jiang, H. (2017) · Microbiology and Immunology · doi:10.1111/1348-0421.12500 · Cited by 13
Boldorini, R. L., Clemente, N., Alchera, E., & Carini, R. (2021) · Clinical Science · doi:10.1042/cs20201091 · Cited by 13
Self-citationTakeshima, R., Kamata, M., Suzuki, S., Ito, M., Watanabe, A., Uchida, H., Chijiwa, C., Okada, Y., Azuma, S., Nagata, M., et al. (2024) · The Journal of Dermatology · doi:10.1111/1346-8138.17277 · Cited by 12
Immune activation induced by dysregulated lipid metabolism in the pathogenesis of type 2 diabetes
Yang, H., Yu, W., Mao, Q., & Zhao, L. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i12.114395 · Cited by 11
Sun, R., Xiang, Z., & Wu, B. (2022) · Portal hypertension & cirrhosis · doi:10.1002/poh2.11 · Cited by 14
Duan, X., Lv, J., Jiang, H., Zheng, K., & Chen, Y. (2022) · Genetics Research · doi:10.1155/2022/8560831 · Cited by 11
The role of dendritic cells in MASH: friends or foes?
Pinto, A. T., & Lukacs‐Kornek, V. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1379225 · Cited by 11
Macrophage-tregs crosstalk: the “hub” of the immune network in MASLD
Zhao, H., Wang, W., Zhu, P., & Shi, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1680878 · Cited by 13
Dong, H., Zhu, F., Shilu, J., & Tian, J. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8707 · Cited by 10
Li, B., Su, R., Yan, H., Liu, J., Gao, C., Li, X., & Wang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907729 · Cited by 9
Yoshikawa, S., Taniguchi, K., Sawamura, H., Ikeda, Y., Asai, T. T., Tsuji, A., & Matsuda, S. (2023) · Livers · doi:10.3390/livers3010002 · Cited by 9
Shi, C., Su, C., Cen, L., Han, L., Tang, J., Wang, Z., Shi, X., Ju, D., Cao, Y., & Zhu, H. (2023) · Biomedicines · doi:10.3390/biomedicines11041160 · Cited by 9
M. S. Barron, A., Fabre, T., & De, S. (2024) · F1000Research · doi:10.12688/f1000research.143472.1 · Cited by 8
The Role of CD4+T Cells in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
Miao, Y., Li, Z., Feng, J., Lei, X., Shan, J., Qian, C., & Li, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136895 · Cited by 12
Navigating the Paradox of IL‐22: Friend or Foe in Hepatic Health?
Qin, J., Zhu, W., & Zhou, W. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16991 · Cited by 8
The Roles of T Cells in the Development of Metabolic Dysfunction‐Associated Steatohepatitis
Ge, Z., Wu, Q., Lv, C., & He, Q. (2025) · Immunology · doi:10.1111/imm.13943 · Cited by 8
The impact of T cells on immune-related liver diseases: an overview
Koda, Y., Kasuga, R., Taniki, N., Kanai∥, T., & Nakamoto, N. (2025) · Inflammation and Regeneration · doi:10.1186/s41232-025-00387-0 · Cited by 11
MASLD and MASLD-associated HCC: emerging biomarkers and therapeutic avenues
Ha, S., Zhang, X., Lan-juan, L., & Yu, J. (2026) · 中国科学通报:英文版 · doi:10.1016/j.scib.2026.04.048 · Cited by 8
Bertran, L., Portillo-Carrasquer, M., Barrientos‐Riosalido, A., Aguilar, C., Riesco, D., Martínez, S., Culebradas, A., Vives, M., Sabench, F., Castillo, D. D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179871 · Cited by 7
Immunology and treatments of fatty liver disease
Tang, S., Wu, S., Zhang, W., Ma, L., Zuo, L., & Wang, H. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03920-1 · Cited by 6
Fatty liver-index, systemic inflammation and cardiovascular mortality. Results from the LURIC study
Wissel, S., Scharnagl, H., Kleber, M. E., Delgado, G., Moissl, A. P., Krämer, B. K., & März, W. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120557 · Cited by 6
Chen, C., Chang, Z., Tsai, F., & Chen, S. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.338 · Cited by 7
Role of CD4+ T-cells in the pathology of non-alcoholic fatty liver disease and related diseases
Seike, T., Mizukoshi, E., & Kaneko, S. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2021.46 · Cited by 6
Su, S.-B., Chen, W., Huang, F., & Zhang, J. (2018) · European Journal of Inflammation · doi:10.1177/2058739218802678 · Cited by 6
Kanmani, P., Villena, J., Lim, S.-K., Song, E., Nam, Y., & Kim, H. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400227 · Cited by 6
He, R., Guan, C., Zhao, X., Yu, L., & Cui, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1364442 · Cited by 6
Wu, Y., Tan, L., Shi, L., Yang, Z., Xue, Y., Zeng, T., Shi, Y., Lin, Y., & Liu, L. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8778 · Cited by 6
Chen, Y., Jia, B., Tong, X., Yin, S., Ni, W., Zhao, Q., Shi, J., & Li, J. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000864 · Cited by 6
Li, X., Jin, K., Fang, J., Ma, X., He, J., Lu, A., Jia, Z., & Shi, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1835197 · Cited by 4
Higashikawa, K., Horiguchi, S., Tarisawa, M., Shibata, Y., Ohkura, K., Yasui, H., Takeda, H., & Kuge, Y. (2019) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2019.12.006 · Cited by 4
Immune cell profile and immune‐related gene expression of obese peripheral blood and liver tissue
Taylor, J. M., Li, A. S., & McLachlan, C. S. (2021) · FEBS Letters · doi:10.1002/1873-3468.14248 · Cited by 4
Gong, Y., Liu, H., & Tao, L. (2019) · Bioscience Reports · doi:10.1042/bsr20181716 · Cited by 4
RetractedThe immunometabolic nature of MASH: framing immune cells within metabolic dysfunction
González-Serrano, S., Onoiu, A.-I., Jiménez-Franco, A., Cambra-Cortés, V., Camps, J., & Joven, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1797949 · Cited by 4
Chen, T., Shan, S., Chen, Y.-N., Li, M.-Q., Zhang, H., Li, L., Gao, P.-P., Li, N., Huang, Y., Li, X., et al. (2025) · Archives of Pharmacal Research · doi:10.1007/s12272-025-01544-2 · Cited by 4
Nonalcoholic Fatty Liver Disease
Alazawi, W., & Hirschfield, G. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_21 · Cited by 3
Yin, M., Zhang, Y., Liu, S., & Li, X. (2026) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-026-00921-z · Cited by 2
CHARACTERISTICS OF THE IMMUNE STATUS IN PATIENTS WITH DECOMPENSATION OF LIVER CIRRHOSIS
Ivanova, A. L., Карзакова, Л. М., Odintsova, A. V., Игоревич, К. С., Bagildinskaya, M. V., & Vladimirovna, Z. N. (2023) · Acta medica Eurasica · doi:10.47026/2413-4864-2023-1-53-62 · Cited by 2
Pyruvate Oxidation Sustains B Cell Antigen-Specific Activation to Exacerbate MASHPreprint
Barrow, F., Wang, H., Fredrickson, G., Florczak, K. L., Ciske, E., Khanal, S., Parthiban, P., Huy, N. T., Rios, E., Kostallari, E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.13.566832 · Cited by 3
Abdelnabi, M. N., Maali, Y., Dabbaghizadeh, A., Mokariasl, N., Dion, J., Yamak, R., Soucy, G., Hassan, G. S., & Shoukry, N. H. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkaf332 · Cited by 1
Chng, W. Q., Liew, J. J., Liew, C. F., Muthiah, M., Zheng, M., & Oon, H. H. B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1831174 · Cited by 1
Wu, T., Hu, J., Wang, X., Luo, X., Wang, H., & Ning, Q. (2021) · BioFactors · doi:10.1002/biof.1811 · Cited by 1
Vizioli, G., Nicoletti, A., Daniela, F., Funaro, B., Verme, L. Z. D., Ponziani, F. R., Zocco, M. A., Gasbarrini, A., & Gabrielli, M. (2025) · Applied Sciences · doi:10.3390/app15052279 · Cited by 3
Liver immunology: Biological role and clinical significance
Kotlyarov, S. N. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i7.107541 · Cited by 6
Gulubova, M. V., Hadzhi, M., Hadzhilieva, L., Chonov, D. C., & Ignatova, M. (2021) · Acta Medica Bulgarica · doi:10.2478/amb-2021-0037
Liu, B., Tian, Y., He, J., Gu, Q., Jin, B., Shen, H., Li, W., Shi, L., Yu, H., Shan, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20921202
Liu, B., Tian, Y., He, J., Gu, Q., Jin, B., Shen, H., Li, W., Shi, L., Yu, H., Shan, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20921211
Liu, B., Tian, Y., He, J., Gu, Q., Jin, B., Shen, H., Li, W., Shi, L., Yu, H., Shan, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20921217
Liu, B., Tian, Y., He, J., Gu, Q., Jin, B., Shen, H., Li, W., Shi, L., Yu, H., Shan, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20921208
Liu, B., Tian, Y., He, J., Gu, Q., Jin, B., Shen, H., Li, W., Shi, L., Yu, H., Shan, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20921205
Research Progress on the Correlation between Lymphocytes and Non-Alcoholic Fatty Liver Disease
肖, 传. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.151095
Li, Y., Lv, X., Li, S., Lin, G., Lin, G., Huang, Z., Chen, D., Zhan, L., Zhan, L., & Lv, X. (2025) · Open Medicine · doi:10.1515/med-2025-1154
Sun, J., & Wang, W. (2025) · International Conference on Health Big Data · doi:10.1145/3733006.3733031
Liu, B., Tian, Y., He, J., Gu, Q., Jin, B., Shen, H., Li, W., Shi, L., Yu, H., Shan, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20921187
Liu, B., Tian, Y., He, J., Gu, Q., Jin, B., Shen, H., Li, W., Shi, L., Yu, H., Shan, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20921193
Liu, B., Tian, Y., He, J., Gu, Q., Jin, B., Shen, H., Li, W., Shi, L., Yu, H., Shan, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20921199
IL - 17 et réponse inflammatoire systémique : focus sur le foie et le muscle
Beringer, A. (2018) · theses.fr (ABES) · doi:10.70675/2d9a348ez5879z4d92z938fz1e4047d398bc
Changes in the FIB-4 index with IL-23 vs IL-17 inhibitors in psoriasis: a retrospective cohort study
Demirbaş, G. U., Demirbaş, A., & Diremsizoğlu, E. (2026) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2026.2746892
Metadata
- Authors
- Rolla, S., Alchera, E., Imarisio, C., Bardina, V., Valente, G., Cappello, P., Mombello, C., Follenzi, A., Novelli, F., & Carini, R.
- Affiliations
- Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT)
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- ORCID
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2015-12-17
- Volume
- 130
- Issue
- 3
- Pages
- 193-203
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2196060005
- Cited by
- 158
- References
- 80
- Citations by year
- 2026: 7 · 2025: 18 · 2024: 15 · 2023: 20 · 2022: 23 · 2021: 23 · 2020: 16 · 2019: 12 · 2018: 9 · 2017: 9 · 2016: 6
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- nonalcoholic steatohepatitis, IL-17, IL-22, Th17 cells, Th22 cells, CD4+ T helper cells, liver fibrosis, steatosis, methionine-choline-deficient diet, palmitate, JNK signaling, PI3K/Akt signaling, PTEN, CCL20, interleukin-6, TNF-α, TGF-beta, IL-17 inhibitors
- MeSH terms
- Interleukin-22, Animals, Disease Models, Animal, T-Lymphocytes, Helper-Inducer, Interleukins, Liver, Male, Mice, Inbred C57BL, Interleukin-17, T-Lymphocytes, Regulatory, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.